Arkolith/Insider Trading/RKDA/Form 4

Kawakami Mark

Chief Financial OfficerArcadia Biosciences, Inc. (RKDA) · full profile →Form 4 · filed Aug 20, 2024
Net Buying
Open-Market Buys
$1K
Open-Market Sells
$0
Net Open-Market Flow
$1K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2024Buy(P)700$2.06$1K2K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-099338) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML